Rod Syoc

Sr. Director, Clinical Operations at Cellerant Therapeutics - San Carlos, California, United States

Rod Syoc's Contact Details
HQ
Location
Los Altos,California,United States
Company
Cellerant Therapeutics
Rod Syoc's Company Details
Cellerant Therapeutics logo, Cellerant Therapeutics contact details

Cellerant Therapeutics

San Carlos, California, United States • 5 Employees
Research

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant's romyelocel-L is a universal cell therapy which does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. In a randomized, controlled Phase 2 clinical trial in AML patients, romyelocel-L reduced infections and days in hospital. Cellerant is developing two novel antibody drug-conjugate (ADC) products: CLT030 to treat AML by selectively targeting and killing leukemic stem and blast cells, and CSC012-ADC for hematologic malignancies and solid tumor indications.

Details about Cellerant Therapeutics
Frequently Asked Questions about Rod Syoc
Rod Syoc currently works for Cellerant Therapeutics.
Rod Syoc's role at Cellerant Therapeutics is Sr. Director, Clinical Operations.
Rod Syoc's email address is ***@cellerant.com. To view Rod Syoc's full email address, please signup to ConnectPlex.
Rod Syoc works in the Research industry.
Rod Syoc's colleagues at Cellerant Therapeutics are Julie Christensen, Trang Nguyen, Luqman Gbenro, Myralee Martinez, Helen Gebremicael, Chitra Saraiya, Lane Welton and others.
Rod Syoc's phone number is
See more information about Rod Syoc